Arcus Biosciences Stock Probability of Future Stock Price Finishing Over 17.49
| RCUS Stock | USD 15.65 0.44 2.73% |
Closest to current price Arcus long CALL Option Payoff at Expiration
Arcus |
Arcus Biosciences Target Price Odds to finish over 17.49
The tendency of Arcus Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 17.49 or more in 90 days |
| 15.65 | 90 days | 17.49 | about 21.28 |
Based on a normal probability distribution, the odds of Arcus Biosciences to move over $ 17.49 or more in 90 days from now is about 21.28 (This Arcus Biosciences probability density function shows the probability of Arcus Stock to fall within a particular range of prices over 90 days) . Probability of Arcus Biosciences price to stay between its current price of $ 15.65 and $ 17.49 at the end of the 90-day period is about 56.43 .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.54 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Arcus Biosciences will likely underperform. Additionally Arcus Biosciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. Arcus Biosciences Price Density |
| Price |
Predictive Modules for Arcus Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Arcus Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Arcus Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Arcus Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Arcus Biosciences is not an exception. The market had few large corrections towards the Arcus Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Arcus Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Arcus Biosciences within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | -0.15 | |
β | Beta against NYSE Composite | 2.54 | |
σ | Overall volatility | 1.18 | |
Ir | Information ratio | -0.05 |
Arcus Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Arcus Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Arcus Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Arcus Biosciences generated a negative expected return over the last 90 days | |
| Arcus Biosciences has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 117 M. Net Loss for the year was (307 M) with loss before overhead, payroll, taxes, and interest of (176 M). | |
| Arcus Biosciences currently holds about 1.05 B in cash with (306 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 14.48. | |
| Arcus Biosciences has a poor financial position based on the latest SEC disclosures | |
| Roughly 60.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Arcus Biosciences Announces New Employment Inducement Grants - businesswire.com |
Arcus Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Arcus Stock often depends not only on the future outlook of the current and potential Arcus Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Arcus Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 74 M | |
| Cash And Short Term Investments | 759 M |
Arcus Biosciences Technical Analysis
Arcus Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Arcus Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Arcus Biosciences. In general, you should focus on analyzing Arcus Stock price patterns and their correlations with different microeconomic environments and drivers.
Arcus Biosciences Predictive Forecast Models
Arcus Biosciences' time-series forecasting models is one of many Arcus Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Arcus Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Arcus Biosciences
Checking the ongoing alerts about Arcus Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Arcus Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Arcus Biosciences generated a negative expected return over the last 90 days | |
| Arcus Biosciences has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 117 M. Net Loss for the year was (307 M) with loss before overhead, payroll, taxes, and interest of (176 M). | |
| Arcus Biosciences currently holds about 1.05 B in cash with (306 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 14.48. | |
| Arcus Biosciences has a poor financial position based on the latest SEC disclosures | |
| Roughly 60.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Arcus Biosciences Announces New Employment Inducement Grants - businesswire.com |
Additional Tools for Arcus Stock Analysis
When running Arcus Biosciences' price analysis, check to measure Arcus Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcus Biosciences is operating at the current time. Most of Arcus Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcus Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcus Biosciences' price. Additionally, you may evaluate how the addition of Arcus Biosciences to your portfolios can decrease your overall portfolio volatility.